Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPBP) Non-Current Deffered Revenue (2020 - 2025)

Historic Non-Current Deffered Revenue for National Healthcare Properties (NHPBP) over the last 6 years, with Q3 2025 value amounting to $10.2 million.

  • National Healthcare Properties' Non-Current Deffered Revenue rose 7894.0% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year increase of 7894.0%. This contributed to the annual value of $7.2 million for FY2024, which is 1103.08% up from last year.
  • Latest data reveals that National Healthcare Properties reported Non-Current Deffered Revenue of $10.2 million as of Q3 2025, which was up 7894.0% from $9.3 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' Non-Current Deffered Revenue registered a high of $10.2 million during Q3 2025, and its lowest value of $5.5 million during Q2 2023.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $6.5 million (2024), whereas its average is $7.1 million.
  • In the last 5 years, National Healthcare Properties' Non-Current Deffered Revenue crashed by 3125.65% in 2022 and then soared by 7894.0% in 2025.
  • Over the past 5 years, National Healthcare Properties' Non-Current Deffered Revenue (Quarter) stood at $8.6 million in 2021, then crashed by 31.26% to $5.9 million in 2022, then increased by 9.7% to $6.5 million in 2023, then increased by 11.03% to $7.2 million in 2024, then skyrocketed by 41.75% to $10.2 million in 2025.
  • Its last three reported values are $10.2 million in Q3 2025, $9.3 million for Q2 2025, and $8.3 million during Q1 2025.